Evidence map›Paper›PMID 18183307›Full record

ArticlePloS one2008

Importance of a C-terminal conserved region of Chk1 for checkpoint function.

Carmela Palermo, Justin C Hope, Greg A Freyer, Hui Rao, Nancy C Walworth

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Roles of Chk1 in cell biology and cancer therapy.International journal of cancer · 2014
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Regulation of chk1.Cell division · 2009
    Article
  12. ATRMec1 phosphorylation-independent activation of Chk1 in vivo.The Journal of biological chemistry · 2009
    Article
  13. Regulation of Chk1 by its C-terminal domain.Molecular biology of the cell · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carmela PalermoDepartment of Pharmacology, University of Medicine and Dentistry, New Jersey (UMDNJ), Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
Justin C Hope
Greg A Freyer
Hui Rao
Nancy C Walworth
Rutgers, The State University of New Jersey · USColumbia University · US

Funding

Cell Cycle Checkpoint in Response to DNA DamageR01GM053194 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WALWORTH, NANCY C. · 1995 to 2011
$4.4M
NIGMS NIH HHS GM53194NIGMS NIH HHS R01 GM053194
6 · The paper itself

Abstract

backgroundThe protein kinase Chk1 is an essential component of the DNA damage checkpoint pathway. Chk1 is phosphorylated and activated in the fission yeast Schizosaccharomyces pombe when cells are exposed to agents that damage DNA. Phosphorylation, kinase activation, and nuclear accumulation are events critical to the ability of Chk1 to induce a transient delay in cell cycle progression. The catalytic domain of Chk1 is well-conserved amongst all species, while there are only a few regions of homology within the C-terminus. A potential pseudosubstrate domain exists in the C-terminus of S. pombe Chk1, raising the possibility that the C-terminus acts to inhibit the catalytic domain through interaction of this domain with the substrate binding site. METHODOLOGY/PRINCIPAL

findingsTo evaluate this hypothesis, we characterized mutations in the pseudosubstrate region. Mutation of a conserved aspartic acid at position 469 to alanine or glycine compromises Chk1 function when the mutants are integrated as single copies, demonstrating that this domain of Chk1 is critical for function. Our data does not support, however, the hypothesis that the domain acts to inhibit Chk1 function as other mutations in the amino acids predicted to comprise the pseudosubstrate do not result in constitutive activation of the protein. When expressed in multi-copy, Chk1D469A remains non-functional. In contrast, multi-copy Chk1D469G confers cell survival and imposes a checkpoint delay in response to some, though not all forms of DNA damage. CONCLUSIONS/SIGNIFICANCE: Thus, we conclude that this C-terminal region of Chk1 is important for checkpoint function and predict that a limiting factor capable of associating with Chk1D469G, but not Chk1D469A, interacts with Chk1 to elicit checkpoint activation in response to a subset of DNA lesions.

Indexed as

AllelesCamptothecinCheckpoint Kinase 1DNA DamageDNA, FungalMutationProtein KinasesSchizosaccharomycesSchizosaccharomyces pombe ProteinsSubstrate SpecificityUltraviolet RaysCamptothecinCheckpoint Kinase 1Chk1 protein, S pombeDNA, FungalProtein KinasesSchizosaccharomyces pombe Proteins

Identifiers

PMID18183307
PMCPMC2173936
OpenAlexW2027391273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.